Your funds, side by side
The lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- Goldman Sachs Future Health Care Equity ETF Goldman Sachs ETF Trust · 39 lines · as of Feb 28, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | Goldman Sachs Future Health Care Equity ETF |
|---|---|
| Eli Lilly & Co | 12.19 % |
| Johnson & Johnson | 8.09 % |
| AstraZeneca PLC | 6.40 % |
| Merck & Co Inc | 5.98 % |
| Boston Scientific Corp | 5.80 % |
| Thermo Fisher Scientific Inc | 4.61 % |
| Intuitive Surgical Inc | 4.46 % |
| Guardant Health Inc | 3.73 % |
| Hoya Corp | 3.62 % |
| Argenx SE | 3.60 % |
| Cencora Inc | 3.38 % |
| Abbott Laboratories | 3.13 % |
| Lonza Group AG | 2.94 % |
| Agilent Technologies Inc | 2.90 % |
| Dexcom Inc | 2.68 % |
| Roivant Sciences Ltd | 2.22 % |
| Mettler-Toledo International Inc | 1.77 % |
| Apogee Therapeutics Inc | 1.62 % |
| Sartorius Stedim Biotech | 1.59 % |
| Ionis Pharmaceuticals Inc | 1.41 % |
| QIAGEN NV | 1.39 % |
| Repligen Corp | 1.26 % |
| Insmed Inc | 1.22 % |
| Penumbra Inc | 1.14 % |
| Natera Inc | 1.05 % |
| Xenon Pharmaceuticals Inc | 1.03 % |
| Royalty Pharma PLC | 1.01 % |
| UnitedHealth Group Inc | 1.01 % |
| Cytokinetics Inc | 0.98 % |
| Bridgebio Pharma Inc | 0.92 % |
1 funds, 39 lines read.